Related Experiment Video
Updated: May 6, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
Published on: February 21, 2018
Continuing clozapine with granulocyte colony-stimulating factor in patients with neutropenia
Al Aditya Khan1, Jake Harvey, Samrat Sengupta
1Consultant in Forensic Psychiatry, Bracton Centre, Bracton Lane, Dartford, Kent DA2 7AF, UK.
Background:
The current guidelines dictate that clozapine should be stopped following the emergence of neutropenia. Various alternative approaches have been tried in the past, among them one rarely used alternative being to continue treatment with clozapine with coprescription of granulocyte colony-stimulating factor (G-CSF).
Aim And Method:
In this case series we aim to describe the treatment and progress of a number of patients in a secure psychiatric hospital in the UK. These patients were restarted on clozapine in combination with G-CSF, in spite of previous neutropenia associated with clozapine treatment.
Discussion And Conclusion:
We hope that this case series will raise the profile of a potentially effective alternative to discontinuing clozapine after neutropenia.
More Related Videos
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Differentiation of Common Myeloid Progenitor Cells
Psychosis: Goals of Pharmacotherapy
Cystic Fibrosis: Management
Sinus disease and chronic...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

